AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 129 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,028 | +74.8% | 243,600 | +28.5% | 0.05% | +84.6% |
| Q2 2023 | $588 | +58.5% | 189,560 | -29.0% | 0.03% | +44.4% |
| Q1 2023 | $371 | -43.6% | 266,802 | -19.3% | 0.02% | -50.0% |
| Q4 2022 | $658 | -99.9% | 330,458 | +50.3% | 0.04% | +33.3% |
| Q3 2022 | $444,000 | -41.1% | 219,868 | -7.3% | 0.03% | -52.6% |
| Q2 2022 | $754,000 | -38.1% | 237,161 | -18.8% | 0.06% | -28.8% |
| Q1 2022 | $1,218,000 | +151.1% | 292,059 | +188.6% | 0.08% | +31.1% |
| Q4 2021 | $485,000 | -51.9% | 101,193 | -46.5% | 0.06% | -54.5% |
| Q3 2021 | $1,009,000 | +91.5% | 189,037 | +83.8% | 0.13% | -24.3% |
| Q2 2021 | $527,000 | +66.8% | 102,860 | +118.9% | 0.18% | +75.2% |
| Q1 2021 | $316,000 | -49.2% | 46,990 | -63.6% | 0.10% | -45.7% |
| Q4 2019 | $622,000 | +232.6% | 129,020 | +100.4% | 0.19% | +165.7% |
| Q3 2019 | $187,000 | – | 64,390 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |